ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis
Conference Coverage
Alemtuzumab-induced autoimmunity: getting closer to answers
Researchers are getting closer to identifying MS patients more susceptible to secondary autoimmunity after alemtuzumab treatment.
Conference Coverage
High dose of novel compound for relapsing-remitting MS shows promise
SAN DIEGO – Evidence of remyelination observed at 24 weeks.
Conference Coverage
Researchers find predictors of worse MS outcomes in post hoc study of three trials
Predicting which people with MS might experience relapse or progression of disability could help clinicians more closely follow those at higher...
Conference Coverage
Fingolimod switch from an injectable linked to improved outcomes in relapsing MS
SAN DIEGO – The benefit of the switch was observed regardless of previous treatment status.
Conference Coverage
Extended-interval dosing of natalizumab linked to lower risk of PML
SAN DIEGO – Dangerous viral brain disease is more likely to strike at-risk MS patients who rely on standard-interval dosing.
Conference Coverage
Is MS caused by one-two punch of pinworm and Epstein-Barr virus?
SAN DIEGO – New theory suggests a double hit of infections could prime people to develop the disease.
Conference Coverage
Study identifies characteristics that may constitute the MS prodrome
SAN DIEGO - Some neurologic health problems may be early signs of multiple sclerosis
Conference Coverage
Physicians often bypass cognition, depression screening in MS
SAN DIEGO - Physicians who did perform screening hardly ever used validated tools.
Conference Coverage
Nearly half of MS patients treated by primary docs miss out on meds
SAN DIEGO – Patients at specialty centers are much more likely to receive disease-modifying therapies despite having fewer symptoms.
Conference Coverage
VIDEO: Teriflunomide and dimethyl fumarate are comparable in relapsing-remitting MS
SAN DIEGO – Small study of oral drugs finds they’re similar in terms of efficacy and adverse effects, and both can be used “with equal confidence...
Conference Coverage
VIDEO: Advanced practice providers take on many roles in MS care
SAN DIEGO – Survey finds most MS advanced practice providers are highly satisfied with their jobs, patients, and colleagues.
Conference Coverage
‘Real-world evidence’ used to compare agents for relapsing-remitting MS
SAN DIEGO – The comparative effectiveness of delayed-release dimethyl fumarate was analyzed against fingolimod and glatiramer acetate.
Conference Coverage
Trial of clozapine, risperidone halted in MS
SAN DIEGO – Adverse events led to participants’ withdrawal.
Conference Coverage
VIDEO: Managing the alemtuzumab paradox
SAN DIEGO – Dr. Alasdair Coles explains the best management approach for this “high risk, high gain” drug.
Conference Coverage
Third course of alemtuzumab can improve MS outcomes
SAN DIEGO – Patients who experience radiographic relapse after two courses of alemtuzumab may not be treatment failures.